Published in TB and Outbreaks Week, April 24th, 2001
But, research published by an American group in the April 14, 2001, issue of the Lancet suggests that these harmful bacteria have already built up a resistance to the newest drugs.
Linezolid is a new antibiotic, which received approval from the U.S. Food and Drug Administration at the beginning of 2000. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.